SHG:603566 - Pulike Biological Engineering Inc

Pulike Biological Engineering
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.12B 2.9%	2.17B 2.3%	2.24B 3.5%	2.3B 2.3%	3.26B 42.1%	3.4B 4.1%	3.38B -0.4%	3.33B -1.6%	3.35B 0.5%	3.26B -2.5%	3.21B -1.7%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	852.36M 0.0%	733.43M -14.0%	811.32M 10.6%	818.55M 0.9%	1.71B 108.3%	1.68B -1.3%	1.59B -5.7%	1.51B -4.6%	1.51B -0.4%	1.41B -6.6%	1.31B -7.0%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	335.42M 12.8%	243.83M -27.3%	252.95M 3.7%	224.42M -11.3%	1.07B 375.6%	973.01M -8.8%	875.77M -10.0%	771.12M -11.9%	836.75M 8.5%	724.79M -13.4%	643.16M -11.3%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.27B 4.9%	1.43B 13.2%	1.43B -0.2%	1.48B 3.1%	1.56B 5.4%	1.71B 10.0%	1.8B 4.8%	1.82B 1.2%	1.84B 1.2%	1.85B 0.8%	1.89B 2.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	337.17M -2.3%	367.83M 9.1%	406.01M 10.4%	478.13M 17.8%	506.21M 5.9%	591.56M 16.9%	519.02M -12.3%	535.11M 3.1%	611.03M 14.2%	538.33M -11.9%	471.72M -12.4%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	308.58M -2.7%	345.59M 12.0%	376.88M 9.1%	453.33M 20.3%	478.13M 5.5%	556.13M 16.3%	480.27M -13.6%	497.77M 3.6%	570.72M 14.7%	508.03M -11.0%	436.33M -14.1%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	28.59M 2.4%	22.24M -22.2%	29.13M 31.0%	24.81M -14.8%	28.08M 13.2%	35.42M 26.2%	38.74M 9.4%	37.34M -3.6%	40.31M 8.0%	30.31M -24.8%	35.4M 16.8%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.78B 3.9%	1.8B 1.0%	1.84B 2.1%	1.82B -1.1%	2.76B 51.6%	2.8B 1.7%	2.86B 2.1%	2.79B -2.4%	2.74B -2.1%	2.72B -0.4%	2.73B 0.4%
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.78B 3.9%	1.8B 1.0%	1.84B 2.1%	1.82B -1.1%	2.76B 51.6%	2.8B 1.7%	2.86B 2.1%	2.79B -2.4%	2.74B -2.1%	2.72B -0.4%	2.73B 0.4%
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-